199 related articles for article (PubMed ID: 29288496)
1. CHA
Su CH; Tsao TF; Chen AC; Chang KW; Yang YS; Ueng KC; Tsai CF
Eur J Clin Invest; 2018 Mar; 48(3):. PubMed ID: 29288496
[TBL] [Abstract][Full Text] [Related]
2. Do physicians correctly calculate thromboembolic risk scores? A comparison of concordance between manual and computer-based calculation of CHADS2 and CHA2 DS2 -VASc scores.
Esteve-Pastor MA; Marín F; Bertomeu-Martinez V; Roldán-Rabadán I; Cequier-Fillat Á; Badimon L; Muñiz-García J; Valdés M; Anguita-Sánchez M;
Intern Med J; 2016 May; 46(5):583-9. PubMed ID: 26929032
[TBL] [Abstract][Full Text] [Related]
3. The association between asymptomatic coronary artery disease and CHADS2 and CHA2 DS2 -VASc scores in patients with stroke.
Cha MJ; Lee HS; Kim YD; Nam HS; Heo JH
Eur J Neurol; 2013 Sep; 20(9):1256-63. PubMed ID: 23560528
[TBL] [Abstract][Full Text] [Related]
4. CHA
Mlodawska E; Tomaszuk-Kazberuk A; Lopatowska P; Kaminski M; Musial WJ
Intern Med J; 2017 Mar; 47(3):275-279. PubMed ID: 27860070
[TBL] [Abstract][Full Text] [Related]
5. The role of CHADS2 and CHA2 DS2 -VASc scores in the prediction of stroke in individuals without atrial fibrillation: a population-based study.
Saliba W; Gronich N; Barnett-Griness O; Rennert G
J Thromb Haemost; 2016 Jun; 14(6):1155-62. PubMed ID: 27037960
[TBL] [Abstract][Full Text] [Related]
6. Association of CHA
Hjelholt TJ; Johnsen SP; Brynningsen PK; Pedersen AB
J Am Geriatr Soc; 2020 Aug; 68(8):1698-1705. PubMed ID: 32294240
[TBL] [Abstract][Full Text] [Related]
7. CHADS2 score/CHA2 DS2 -VASc score and major artery occlusion in cardioembolic stroke patients with nonvalvular atrial fibrillation.
Deguchi I; Hayashi T; Ohe Y; Kato Y; Fukuoka T; Maruyama H; Horiuchi Y; Sano H; Nagamine Y; Tanahashi N
Int J Stroke; 2014 Jul; 9(5):576-9. PubMed ID: 24447527
[TBL] [Abstract][Full Text] [Related]
8. Correlation between cardiac rhythm, left atrial appendage flow velocity, and CHA
Zuo K; Sun L; Yang X; Lyu X; Li K
Clin Cardiol; 2017 Feb; 40(2):120-125. PubMed ID: 28075503
[TBL] [Abstract][Full Text] [Related]
9. The co-predictive value of a cardiovascular score for CV outcomes in diabetic patients with no atrial fibrillation.
Patti G; Sticchi A; Pasceri V; Ricci F; Renda G; Hamrefors V; Melander O; Sutton R; Engström G; De Caterina R; Fedorowski A
Diabetes Metab Res Rev; 2019 Jul; 35(5):e3145. PubMed ID: 30790434
[TBL] [Abstract][Full Text] [Related]
10. Refinement of ischemic stroke risk in patients with atrial fibrillation and CHA2 DS2 -VASc score of 1.
Huang D; Anguo L; Yue WS; Yin L; Tse HF; Siu CW
Pacing Clin Electrophysiol; 2014 Nov; 37(11):1442-7. PubMed ID: 25039724
[TBL] [Abstract][Full Text] [Related]
11. Pre-admission CHADS2, CHA2DS2-VASc, and R2CHADS2 Scores on Severity and Functional Outcome in Acute Ischemic Stroke with Atrial Fibrillation.
Tanaka K; Yamada T; Torii T; Furuta K; Matsumoto S; Yoshimura T; Takase K; Wakata Y; Nakashima N; Kira J; Murai H
J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):1629-35. PubMed ID: 25906940
[TBL] [Abstract][Full Text] [Related]
12. Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation.
Tu HT; Campbell BC; Meretoja A; Churilov L; Lees KR; Donnan GA; Davis SM
Cerebrovasc Dis; 2013; 36(4):273-80. PubMed ID: 24135809
[TBL] [Abstract][Full Text] [Related]
13. Time trends in use of the CHADS
Habboushe J; Altman C; Lip GYH
Int J Clin Pract; 2019 Feb; 73(2):e13280. PubMed ID: 30281876
[TBL] [Abstract][Full Text] [Related]
14. Predicting stroke in patients without atrial fibrillation.
Steensig K; Olesen KKW; Thim T; Nielsen JC; Madsen M; Jensen SE; Jensen LO; Kristensen SD; Lip GYH; Maeng M
Eur J Clin Invest; 2019 Jun; 49(6):e13103. PubMed ID: 30883728
[TBL] [Abstract][Full Text] [Related]
15. Augmented intelligence decision tool for stroke prediction combines factors from CHA
Horne BD; Jacobs V; May HT; Graves KG; Bunch TJ
J Cardiovasc Electrophysiol; 2019 Sep; 30(9):1452-1461. PubMed ID: 31115939
[TBL] [Abstract][Full Text] [Related]
16. Use of preoperative CHA2 DS2 -VASc score to predict the risk of atrial fibrillation after cardiothoracic surgery: a nested case-control study from the Atrial Fibrillation Suppression Trials (AFIST) I, II, and III.
Baker WL; Coleman CI; White CM; Kluger J
Pharmacotherapy; 2013 May; 33(5):489-95. PubMed ID: 23649811
[TBL] [Abstract][Full Text] [Related]
17. Risk of ischemic stroke and utility of CHA
Tomasdottir M; Friberg L; Hijazi Z; Lindbäck J; Oldgren J
Clin Cardiol; 2019 Oct; 42(10):1003-1009. PubMed ID: 31490011
[TBL] [Abstract][Full Text] [Related]
18. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.
Jacobs V; May HT; Bair TL; Crandall BG; Cutler M; Day JD; Weiss JP; Osborn JS; Muhlestein JB; Anderson JL; Mallender C; Bunch TJ
Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of CHA
Tourountzis T; Lioulios G; Ginikopoulou E; Stasini F; Skarlatou Z; Stai S; Christodoulou M; Moysidou E; Stangou M
Nephrology (Carlton); 2023 Jul; 28(7):387-398. PubMed ID: 37118866
[TBL] [Abstract][Full Text] [Related]
20. Baseline CHA
Díez-Villanueva P; Vera A; Ariza-Solé A; Formiga F; Martínez-Sellés M; Alegre O; Sanchís J; Marín F; Vidán M; López-Palop R; Abu-Assi E; Bueno H; Alfonso F;
Int J Clin Pract; 2021 Jun; 75(6):e14082. PubMed ID: 33565683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
